awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34344198-C802527C-361D-4B63-BB2C-8EA6BA1B1FFF
Q34344198-C802527C-361D-4B63-BB2C-8EA6BA1B1FFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34344198-C802527C-361D-4B63-BB2C-8EA6BA1B1FFF
Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer.
P2860
Q34344198-C802527C-361D-4B63-BB2C-8EA6BA1B1FFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34344198-C802527C-361D-4B63-BB2C-8EA6BA1B1FFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2daad59bb538a3787a669384bd8ba483ffe3c6dd
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized